These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35522143)

  • 21. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comprehensive diagnostic approach to cardiac events in cancer patients receiving antineoplastic therapy: A systematic review.
    Lafaras C; Kalafatis I; Lafara K; Koukoulitsa V; Mandala E
    Hell J Nucl Med; 2023; 26 Suppl():5-11. PubMed ID: 37658551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies to Prevent Cardiotoxicity.
    Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
    Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel approaches to the prediction, diagnosis and treatment of cardiac late effects in survivors of childhood cancer: a multi-centre observational study.
    Skitch A; Mital S; Mertens L; Liu P; Kantor P; Grosse-Wortmann L; Manlhiot C; Greenberg M; Nathan PC
    BMC Cancer; 2017 Aug; 17(1):519. PubMed ID: 28774277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protecting the heart in cancer therapy.
    Finet JE; Tang WHW
    F1000Res; 2018; 7():. PubMed ID: 30345014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current and emerging modalities for detection of cardiotoxicity in cardio-oncology.
    Khouri MG; Klein MR; Velazquez EJ; Jones LW
    Future Cardiol; 2015 Jul; 11(4):471-84. PubMed ID: 26235924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2.
    Manolis AA; Manolis TA; Mikhailidis DP; Manolis AS
    Expert Opin Drug Saf; 2018 Sep; 17(9):893-915. PubMed ID: 30126303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
    Tajiri K; Aonuma K; Sekine I
    Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac Complications of Cancer Therapy: Pathophysiology, Identification, Prevention, Treatment, and Future Directions.
    Jain D; Russell RR; Schwartz RG; Panjrath GS; Aronow W
    Curr Cardiol Rep; 2017 May; 19(5):36. PubMed ID: 28374177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular Magnetic Resonance Imaging: Identifying the Effects of Cancer Therapy.
    Houbois CP; Thavendiranathan P; Wintersperger BJ
    J Thorac Imaging; 2020 Jan; 35(1):12-25. PubMed ID: 31211728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging Cardiac Imaging Modalities for the Early Detection of Cardiotoxicity Due to Anticancer Therapies.
    López-Fernández T; Thavendiranathan P
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):487-495. PubMed ID: 28189542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced Echocardiographic Techniques in Cardio-Oncology: the Role for Early Detection of Cardiotoxicity.
    Cobarro Gálvez L; Arbas Redondo E; Contreras Lorenzo C; López Fernández T
    Curr Cardiol Rep; 2022 Sep; 24(9):1109-1116. PubMed ID: 35881319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on the risk prediction and prevention of anticancer therapy-induced cardiotoxicity.
    Bhave M; Shah AN; Akhter N; Rosen ST
    Curr Opin Oncol; 2014 Nov; 26(6):590-9. PubMed ID: 25233068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardio-Oncology in Childhood: State of the Art.
    Bennati E; Girolami F; Spaziani G; Calabri GB; Favre C; Parrini I; Lucà F; Tamburini A; Favilli S
    Curr Oncol Rep; 2022 Dec; 24(12):1765-1777. PubMed ID: 36181610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biomarkers in cardio-oncology patients].
    Totzeck M; Glas M; Rassaf T
    Internist (Berl); 2020 Nov; 61(11):1114-1119. PubMed ID: 33025124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-Modality Imaging in the Assessment of Cardiovascular Toxicity in the Cancer Patient.
    Plana JC; Thavendiranathan P; Bucciarelli-Ducci C; Lancellotti P
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1173-1186. PubMed ID: 30092972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced Imaging Modalities to Monitor for Cardiotoxicity.
    Seraphim A; Westwood M; Bhuva AN; Crake T; Moon JC; Menezes LJ; Lloyd G; Ghosh AK; Slater S; Oakervee H; Manisty CH
    Curr Treat Options Oncol; 2019 Aug; 20(9):73. PubMed ID: 31396720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiotoxicity of Chemotherapeutic Drugs: An Update and Future Perspectives.
    Bannister C; Cannata A; Bromage DI; McDonagh T
    J Cardiovasc Pharmacol; 2022 Oct; 80(4):502-514. PubMed ID: 35067533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer as a Risk Factor for Cardiovascular Disease.
    Giza DE; Iliescu G; Hassan S; Marmagkiolis K; Iliescu C
    Curr Oncol Rep; 2017 Jun; 19(6):39. PubMed ID: 28421481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Imaging with Cardiac Computed Tomography in Cardio-Oncology Patients.
    Pitekova B; Ravi S; Shah SV; Mladosievicova B; Heitner S; Ferencik M
    Curr Cardiol Rep; 2016 Sep; 18(9):87. PubMed ID: 27443383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.